| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.053 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |